vimarsana.com

Latest Breaking News On - Nantkwest inc - Page 1 : vimarsana.com

Merkel Cell Carcinoma Treatment Market Size Poised for Remarkable Growth, to Surpass USD 6 59 billio

Merkel Cell Carcinoma Treatment Market Size Poised for Remarkable Growth, to Surpass USD 6 59 billio
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Immunitybio s bladder cancer therapy, Anktiva, gets FDA approval

After several delays, the interleukin-15 superagonist Anktiva (nogapendekin alfa inbakicept) from Immunitybio Inc. has been approved by the U.S. FDA for treating bladder cancer, specifically Bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer with carcinoma in situ, with or without papillary tumors.

California drug company ImmunityBio cuts jobs at Louisville office

ImmunityBio Inc. (Nasdaq: IBRX), a struggling California-based drug company that develops therapies to fight cancers and infectious diseases, is laying off 48 workers in its Louisville satellite office.

California drug company ImmunityBio cuts jobs at Louisville office – BizWest

California drug company ImmunityBio cuts jobs at Louisville office – BizWest
bizwest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizwest.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.